⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3386562 | 0.72 | ALDH1A1 (0.41) | — | |
| SCHEMBL8193 | 0.72 | CCR1 (0.55) | — | |
| SCHEMBL29354893 | 0.72 | CCR1 (0.55) | — | |
| SCHEMBL28304525 | 0.72 | CCR1 (0.55) | — | |
| Hydrochloric Acid SCHEMBL2284189 | 0.69 | CCR1 (0.52) | — | |
| Hydrochloric Acid SCHEMBL16337846 | 0.69 | CCR1 (0.52) | — | |
| Bromide SCHEMBL31044093 | 0.69 | CCR1 (0.52) | — | |
| Ammonia Solution, Strong SCHEMBL2732606 | 0.69 | CCR1 (0.52) | — | |
| Water SCHEMBL8327751 | 0.69 | CCR1 (0.52) | — | |
| Hydrochloric Acid SCHEMBL3704753 | 0.69 | CCR1 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024059745-A2 | N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ANTAGONISTS AND USES THEREOF | BEXSON BIOMEDICAL, INC. (US) | 2024-03-21 | — | — | WO | claimed |
| WO-2024059745-A2 | N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ANTAGONISTS AND USES THEREOF | BEXSON BIOMEDICAL, INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| JP-2024010022-A | BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-b]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-d]PYRIDAZINE AND PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG CANCER, PANCREATIC CANCER OR COLON CANCER | アムジエン・インコーポレーテツド | 2024-01-23 | — | — | JP | disclosed |
| JP-2024010022-A | BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-b]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-d]PYRIDAZINE AND PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG CANCER, PANCREATIC CANCER OR COLON CANCER | アムジエン・インコーポレーテツド | 2024-01-23 | — | — | JP | disclosed |
| WO-2023156398-A1 | ISOTHIAZOLO[3,4-B]PYRIDINES AS HERBICIDES | SYNGENTA CROP PROTECTION AG (CH) | 2023-08-24 | — | — | WO | disclosed |
| US-20230242523-A1 | COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE | FUJIFILM CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| EP-4219465-A2 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme Inc (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-3498701-B1 | PRMT5 INHIBITORS AND USES THEREOF | EPIZYME INC (US) | 2023-02-22 | — | — | EP | disclosed |
| JP-2022110053-A | BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-b]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-d]PYRIDAZINE AND PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG CANCER, PANCREATIC CANCER OR COLON CANCER | アムジエン・インコーポレーテツド | 2022-07-28 | — | — | JP | disclosed |
| JP-2022110053-A | BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-b]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-d]PYRIDAZINE AND PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG CANCER, PANCREATIC CANCER OR COLON CANCER | アムジエン・インコーポレーテツド | 2022-07-28 | — | — | JP | disclosed |
| US-7947815-B2 | Diazenyl isothiazolo[3,4-B]pyridines as dyes | FUJIFILM CORPORATION (JP) | 2011-05-24 | — | — | US | disclosed |
| US-7662193-B2 | Hair dye composition | KAO CORPORATION (JP) | 2010-02-16 | — | — | US | disclosed |
| US-7662193-B2 | Hair dye composition | KAO CORPORATION (JP) | 2010-02-16 | — | — | US | disclosed |
| EP-1381366-B9 | INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC AMIDOPIPERAZINE DERIVATIVES | BRISTOL MYERS SQUIBB CO (US) | 2009-10-21 | — | — | EP | disclosed |
| EP-1381366-B1 | INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC AMIDOPIPERAZINE DERIVATIVES | BRISTOL MYERS SQUIBB CO (US) | 2009-04-22 | — | — | EP | disclosed |
| US-20090049622-A1 | HAIR DYE COMPOSITION | KAO CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20090049622-A1 | HAIR DYE COMPOSITION | KAO CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1847249-A1 | HAIRDYE COMPOSITION | Kao Corporation (JP) | 2007-10-24 | — | — | EP | disclosed |
| US-6825201-B2 | ANTIVIRAL ACTIVITY; TREATMENT OF HIV AND AIDS | BRISTOL-MYERS SQUIBB COMPANY | 2004-11-30 | — | — | US | disclosed |
| US-20030096825-A1 | Indole, azaindole and related heterocyclic amidopiperazine derivatives | VIIV HEALTHCARE UK (NO. 5) LIMITED (GB) | 2003-05-22 | — | — | US | disclosed |